@iselkholi.bsky.social
71 followers 68 following 23 posts
MD, PhD|Oncology Research Fellow, McGill U.| Metastasis, Dormancy & Targeted Therapies|Writing|Coffee|Jazz/blues |🇪🇬➡️🇨🇦 Views are my own.
Posts Media Videos Starter Packs
iselkholi.bsky.social
Different residency positions are also sponsored h1b, which means hospitals/universities would have to pay 100k/sponsored resident!
iselkholi.bsky.social
Stuck at home? Time to revisit the record collection! A record I caught this year in Chicago…
iselkholi.bsky.social
CIHR will finally allow international PhD students to apply! A big step forward!
iselkholi.bsky.social
I still prefer society journals here and all in for this. But the reality is that hiring committees for example might not value society journals (impact factor driven) -dipping my toes in the PI job market here.
The illusion of « elite » science has taken over.
iselkholi.bsky.social
Congrats Julio and all involved. Big step
iselkholi.bsky.social
I am very grateful to CCS for not only supporting my fellowship work but also investing in my career development and being part of academic journey!
ccsresearch.bsky.social
Weekly #cancerresearch highlight: @iselkholi.bsky.social is investigating multiple mutations in a gene called BRAF to understand how they promote #cancer growth and treatment resistance. This could lead to new treatments and better survival for people with these mutations.

Learn more: is.gd/eiibhA
Defining personalized treatment strategies for people with hard-to-treat tumors.
iselkholi.bsky.social
- Asking a nonexpert (outsider) feedback is always helpful. This helped me streamline 2 successful apps that I don’t think would have been viewed the same.

- knowing the audience. À cancer focused committee is different from a diverse molecular biology one for eg.

No memes this time! 😊
iselkholi.bsky.social
Thank you Steve! Hope you would enjoy the read!!
iselkholi.bsky.social
A big thank you to all the co-authors and collaborators on this study for their contributions to bring this to the finish line! @standrapela.bsky.social
@gomeslab.bsky.social
@jaguirreghisolab.bsky.social
And the majority not on BlueSky!
iselkholi.bsky.social
⭐ We also provide three datasets to be mined by the BC metastasis research community: RNA-Seq, WGS, and CRISPR screens on the 4T1 and 4T07 cells.
iselkholi.bsky.social
⭐ Our data suggest that targeting PIK3C3 activity relocalize the lysosomes from the cell periphery to the perinuclear region leading to lower mTORC1 activity in BC cells.
iselkholi.bsky.social
Excited to share our latest discovery just published in Cancer Research.
lnkd.in/e_vNXXJC
⭐ We revealed that dormancy-prone or dormant breast cancer (BC) cells might be eliminated by targeting PIK3C3 (the 3rd class PI3K), hence less #metastasis burden in #breastcancer.
@jf-cotelab.bsky.social
iselkholi.bsky.social
Thank you, Julio for all the insights, support and mentorship through this project!
iselkholi.bsky.social
After 1 year of preparation! #Done
iselkholi.bsky.social
Glad to announce the 1st Basic & Clinical Oncology (BCO) conference on May 7 at the IRCM/Montreal as a partnership between 9 institutes/networks across Quebec! Clinical and basic cancer research abstracts are welcome (deadline April 6). More details: www.ircm.qc.ca/en/events/de...
#Montreal #Quebec
Reposted
quebecscience.bsky.social
🌕🌖🌗🌘🌑🌒🌓🌔Surveillez le ciel dans la nuit du 13 au 14 mars : une éclipse totale de Lune sera au rendez-vous! Cet événement astronomique sera visible depuis le Québec et débutera à 1 h 09 pour se terminer à 4 h 47. L’éclipse atteindra son apogée entre 2 h 59 et 3 h 31.

Voici notre photo prise en 2015.
Éclipse lunaire totale de 2015 dans la région de Montréal.
Reposted
gomeslab.bsky.social
So happy to share the newest pre-print from the lab where we show that old age significantly changes the traits that evolve in established lung adenocarcinoma. This work sheds light into the importance of modeling age-related cancers in the context of old age. www.biorxiv.org/content/10.1...
Aging directs the differential evolution of KRAS-driven lung adenocarcinoma
Lung adenocarcinoma (LUAD), the most common histological subtype of lung cancer( [1][1], [2][2] ), is a disease of the elderly, with an average age of diagnosis of about 70 years of age( [3][3] ). Old...
www.biorxiv.org